Grifols SA - ADR - Level III Live Stock Price Today, Share Analysis and Chart

Name: Grifols SA - ADR - Level III: Is Infosys Ltd. worth buying?
Item: Grifols SA - ADR - Level III
Rating: 2.02166675
Author: Trendlyne DVM scores

about

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once i...

8.78 0.11 (1.27%)

41.84% Gain from 52W Low

490.1K

XNAS Volume

XNAS 26 Nov, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

28.7 / 100

Technically Neutral

52.2 / 100

1Yr Price target upside is 28%

2 analysts

Grifols SA ADR Level III Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..